SB-705498 Completed Phase 2 Trials for Acute Migraine Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00269022Use Of SB-705498 In The Acute Treatment Of Migraine